(Q37850527)

24 August 2017

1 reference

title

Successful use of etanercept for the treatment of Reiter's syndrome: a case report and review of the literature (English)

1 reference

24 August 2017

Amr Edrees

1

1 reference

24 August 2017

publication date

23 July 2011

1 reference

Rheumatology International

24 August 2017

published in

1 reference

24 August 2017

volume

32

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

1-3

1 reference

Reactive arthritis: clinical aspects and medical management

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2000-1

Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2000-1

Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2000-1

Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2000-1

Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2000-1

Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2000-1

Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2000-1

Effect of cytokines on invasion and survival of Yersinia in primary human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2000-1

Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2000-1

TNF involvement and anti-TNF therapy of reactive and unclassified arthritis

21 January 2018

1 reference

12 December 2020

Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor alpha and interferon gamma

1 reference

12 December 2020

Successful use of infliximab in the treatment of Reiter's syndrome: a case report and discussion

1 reference

12 December 2020

On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany,

1 reference

12 December 2020

Arthritis Associated with Yersinia Enterocolitica Infection

1 reference

12 December 2020

Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor

1 reference

12 December 2020

Predictive factors for the longterm outcome of spondyloarthropathies

1 reference

12 December 2020

Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis

1 reference

12 December 2020

Reactive arthritis: incidence, triggering agents and clinical presentation

1 reference

12 December 2020

In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis

1 reference

12 December 2020

Infliximab in the treatment of an HIV positive patient with Reiter's syndrome

1 reference

12 December 2020

10.1007/S00296-011-2000-1

Identifiers

DOI

1 reference

24 August 2017

1 reference